Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Best oral medication

Phase 3Small molecule

UUniversity Hospital Tuebingen

2

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

PARKINSON DISEASE (disorder)Recruiting

PARKINSON DISEASE (disorder)Phase 3

Recruiting

Timeline

Expected Milestones

Q3 2030

Phase 3Recruiting

PARKINSON DISEASE (disorder)

NCT07151378

Clinical

Trials by Indication[1]

PARKINSON DISEASE (Disorder)1 trial

Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

Recruiting·UUniversity Hospital Tuebingen·Phase 3·NCT07151378·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Best oral medication. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Best oral medication compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Best oral medication. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital Tuebingen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity Hospital Tuebingen

Related News